Charité - Universitätsmedizin Berlin
Berlin, 10117, Germany
NCT Number: NCT03920930
In an estimated 150,000 patients, a knee joint replacement is performed in Germany every year. The perioperative care of the patients aims at an optimal surgical technique, which leads to a high functionality in the joint, and above all at an adequate pain treatment. Patients experience pain especially intraoperatively and in the first days after the operation. The intensity of pain is a decisive factor that can hinder the patient's mobilization. In the KneeOptOut study (ethics application number EA4/009/17), which has already been successfully carried out and approved by this ethics committee, it was shown that the use of local infiltration anaesthesia (LIA) for pain therapy after primary knee endoprosthetics is comparable to catheter-supported regional anaesthesia (manuscript under review at the European Journal of Anaesthesiology). During surgery, the morphine requirement of patients in the LIA group was significantly higher than that of patients who underwent catheterization. Postoperatively, however, both subjective pain by VAS and opiate consumption were comparable.
In order to optimize the intraoperative opiate need/consumption, an early-intraoperative procedure for local infiltration anesthesia will now be compared with the previous late-intraoperative procedure. Both procedures correspond to SOP for the treatment of primary knee endoprostheses and are currently used depending on the surgeon's requirements.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Berlin, 10117, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patient receive an infiltration of local anaesthetics around the knee directly after total knee replacement for postoperative pain control.
Other names: late LIA
The local infiltration analgesia is applied in a total of 4 steps during the preparation of the knee joint: 1. after the skin incision, 2. after the capsule incision, 3. after complete exposure of the knee joint, 4. when the posterior knee capsule is reached.
Other names: early LIA
Time frame: intraoperative, up to 3 hours
amount of opioids administered intraoperative measured as equivalent dose to morphin
Time frame: up to 48 hours postoperatively
time from end of surgery until patients is able to stand
Time frame: up to 7 days postoperatively
global satisfaction of patients
Time frame: up to 7 days postoperatively
time from end of surgery until patients is able to walk
Time frame: up to 7 days postoperatively
time to achieve full joint mobility (0/0/90°)
Time frame: up to 24h postoperatively
best Janda grade in both legs the day after surgery
Time frame: up to 7 days postoperatively
intensity of pain in all patients meausered by numeric rating scale (NRS)
Time frame: up to 7 days postoperatively
number of patients requiring rescue pain medication
Time frame: up to 14 days postoperatively
time to discharge from hospital
Time frame: up to 14 days postoperatively
amount of opioids administered until discharge measured as equivalent dose to morphin
Time frame: up to 7 days postoperatively
incidence of postoperative delirium measured by Nursing Delirium Screening Scale (NuDeSc)
Time frame: up to 7 days postoperatively
incidence of PONV
Time frame: intraoperative, up to 3 hours
satisfaction of surgeon in points of clarity of the operative field, change of the operative field by LIA and overall satisfaction represented in one value
Charite University, Berlin, Germany
Other
Optimization of a Fast-track Concept for Knee Replacement: A Single-blind, Randomized, Controlled Clinical Trial
Acronym: KneeOptOut2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03114306
Arthralgia, Joint Diseases
Berlin, Germany
View Trial DetailsNCT05575700
Acute Pain, Agnosia
Brøndby, Denmark
View Trial DetailsNCT04295421
Agnosia, Knee Arthropathy
Tunis, Tunisia
View Trial DetailsNCT05478005
Knee Arthropathy, Neurologic Manifestations
Nahariya, Israel
View Trial Details